These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Non-invasive methods for detection of cardiomyopathy in the course of antineoplastic treatment. Jurga L; Mrinák J; Ponist J; Sefara P; Berc A Neoplasma; 1982; 29(3):341-50. PubMed ID: 7133229 [TBL] [Abstract][Full Text] [Related]
4. [Therapy using cytostatics. Desired and undesired effects]. Hartwich G Fortschr Med; 1973 Nov; 91(31):1218-22. PubMed ID: 4751347 [No Abstract] [Full Text] [Related]
5. Drug management of malignant disease. Fennelly JJ Ir Med J; 1983 Jul; 76(7):326-31. PubMed ID: 6350216 [No Abstract] [Full Text] [Related]
6. [Adriamycin as a single agent in various forms of advanced neoplasia of adults and children (author's transl)]. Bonadonna G; Beretta G; Tancini G; De Palo GM; Gasparini M; Doci R Tumori; 1974; 60(5):373-91. PubMed ID: 4617354 [No Abstract] [Full Text] [Related]
7. Combination chemotherapy with adriamycin (NSC-123127) and 1-(2-chloroethyl)-3-cyclohexyl 1-nitrosourea (CCNU; NSC-79037). Einhorn LH; Livingston RB; Gottlieb JA Cancer Chemother Rep; 1973; 57(4):437-45. PubMed ID: 4586951 [No Abstract] [Full Text] [Related]
8. Echocardiographic assessment of left ventricular function during the injection of adriamycin. Björkhem G; Garwicz S Acta Paediatr Scand; 1977 Sep; 66(5):595-600. PubMed ID: 268924 [TBL] [Abstract][Full Text] [Related]
9. Rituximab induced myocardial infarction: A fatal drug reaction. Arunprasath P; Gobu P; Dubashi B; Satheesh S; Balachander J J Cancer Res Ther; 2011; 7(3):346-8. PubMed ID: 22044821 [No Abstract] [Full Text] [Related]
10. Abdominal pain in a CAPD patient treated with intravenous adriamycin: a chemical peritonitis? Fabris A; Contestabile A; Pellanda MV; Gardin C; De Vivo E; Guerini A Perit Dial Int; 2000; 20(1):93-4. PubMed ID: 10716594 [No Abstract] [Full Text] [Related]
11. [Measurement of systolic time intervals in patients treated with cardiotoxic cytostatic drugs]. Balikó Z; Tornóczky J; Bernáthné TE; Rasch H; Muth L; Lovász E; Tóth A; Gulyás E Orv Hetil; 1982 Jan; 123(5):274-6. PubMed ID: 7063243 [No Abstract] [Full Text] [Related]
12. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992. Andersen MK; Christiansen DH; Jensen BA; Ernst P; Hauge G; Pedersen-Bjergaard J Br J Haematol; 2001 Sep; 114(3):539-43. PubMed ID: 11552977 [TBL] [Abstract][Full Text] [Related]
13. Achievements of cancer chemotherapy. Tobias JS; Whitehouse JM J R Coll Physicians Lond; 1976 Oct; 11(1):59-74. PubMed ID: 789875 [No Abstract] [Full Text] [Related]
14. [Adriamycin (doxorubicin)]. Ogura M Gan To Kagaku Ryoho; 2001 Oct; 28(10):1331-8. PubMed ID: 11681238 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy of cardiac monitoring with echocardiography in adult patients receiving adriamycin]. Okada Y; Sano M Gan To Kagaku Ryoho; 2003 Jun; 30(6):823-7. PubMed ID: 12852350 [TBL] [Abstract][Full Text] [Related]
17. Adriamycin cardiotoxicity in man. Rinehart JJ; Lewis RP; Balcerzak SP Ann Intern Med; 1974 Oct; 81(4):475-8. PubMed ID: 4277990 [No Abstract] [Full Text] [Related]
18. Cell kinetics and in vitro chemosensitivity as a tool for improved management of patients. Silvestrini R; Daidone MG; Costa A; Sanfilippo O Eur J Cancer Clin Oncol; 1985 Mar; 21(3):371-8. PubMed ID: 4007012 [No Abstract] [Full Text] [Related]